Web

More like this

Benjamin Zycher, fellow at the Manhattan Institute, questions of the wisdom of allowing Medicare to negotiate prices with drug companies.
via Ezra Klein comes this bottom-line chart from the Center for Economic and Policy Research:
There's an article in today's Inside Higher Ed on the building momentum in college chemistry courses to make the labs greener -- that is, to reduce the amount of hazardous materials necessary in the required student experime
Some call it "hillbilly heroin," something I could not bring myself to say aloud.  But that illustrates the strong feelings that people have about the drug,